Article Details

GeoVax tumbles as HHS ends mid-stage COVID vaccine trial - TradingView

Retrieved on: 2025-04-14 21:09:11

Tags for this article:

Click the tags to see associated articles and topics

GeoVax tumbles as HHS ends mid-stage COVID vaccine trial - TradingView. View article details on hiswai:

Summary

GeoVax Labs' contract for developing a COVID vaccine, funded by BARDA, was terminated by the U.S. Department of Health and Human Services, impacting its stock. The project had been in mid-stage trials.

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo